Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1293375.RAYj125SimoOCNzz23JB8DN8a3_l3RE7NbMRoxBza9AeQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1293375.RAYj125SimoOCNzz23JB8DN8a3_l3RE7NbMRoxBza9AeQ130_assertion type Assertion NP1293375.RAYj125SimoOCNzz23JB8DN8a3_l3RE7NbMRoxBza9AeQ130_head.
- NP1293375.RAYj125SimoOCNzz23JB8DN8a3_l3RE7NbMRoxBza9AeQ130_assertion description "[Although TP53, NOTCH1, and SF3B1 mutations may impair prognosis of patients with chronic lymphocytic leukemia (CLL) receiving frontline therapy, the impact of these mutations or any other, alone or in combination, remains unclear at relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293375.RAYj125SimoOCNzz23JB8DN8a3_l3RE7NbMRoxBza9AeQ130_provenance.
- NP1293375.RAYj125SimoOCNzz23JB8DN8a3_l3RE7NbMRoxBza9AeQ130_assertion evidence source_evidence_literature NP1293375.RAYj125SimoOCNzz23JB8DN8a3_l3RE7NbMRoxBza9AeQ130_provenance.
- NP1293375.RAYj125SimoOCNzz23JB8DN8a3_l3RE7NbMRoxBza9AeQ130_assertion SIO_000772 26316624 NP1293375.RAYj125SimoOCNzz23JB8DN8a3_l3RE7NbMRoxBza9AeQ130_provenance.
- NP1293375.RAYj125SimoOCNzz23JB8DN8a3_l3RE7NbMRoxBza9AeQ130_assertion wasDerivedFrom befree-2016 NP1293375.RAYj125SimoOCNzz23JB8DN8a3_l3RE7NbMRoxBza9AeQ130_provenance.
- NP1293375.RAYj125SimoOCNzz23JB8DN8a3_l3RE7NbMRoxBza9AeQ130_assertion wasGeneratedBy ECO_0000203 NP1293375.RAYj125SimoOCNzz23JB8DN8a3_l3RE7NbMRoxBza9AeQ130_provenance.